Compound monoammonium glycyrrhizinate injection is mainly used for the treatment of acute and chronic migratory hepatitis, toxic hepatitis, traumatic hepatitis, etc., the specific use of medication is recommended to follow the doctor’s instructions. Compound monoammonium glycyrrhizinate injection is made of monoammonium glycyrrhizinate, cysteine hydrochloride, glycine, with anti-inflammatory, anti-allergic, protective membrane structure, hepatoprotective, etc. It is suitable for the treatment of acute and chronic migratory hepatitis caused by liver function abnormality, adjuvant treatment of toxic hepatitis, traumatic hepatitis, and cancer, or used in food poisoning, drug poisoning, drug allergy and so on. It is contraindicated in patients with hypersensitivity to the product, severe hypokalemia, hypernatremia, hypertension, cardiac failure and renal failure. Adverse effects of the drug include poor appetite, nausea, vomiting, abdominal distension, dry mouth, swelling, headache, dizziness, palpitations, increased blood pressure, itching and urticaria. Specific use of the drug should be under the guidance of a specialist, not unauthorized use of drugs.